Jagsonpal Pharmaceuticals Ltd JAGSNPHARM-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 07/05/22 IST
319.95UNCH (UNCH)
52 week range
123.00 - 369.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close319.95
  • 52 Week High369.00
  • 52 Week High Date04/04/22
  • 52 Week Low123.00
  • 52 Week Low Date11/29/21

Key Stats

  • Market Cap103.02M
  • Shares Out26.2M
  • 10 Day Average Volume41,816.77
  • Dividend4.50
  • Dividend Yield1.41%
  • Beta-
  • YTD % Change78.39

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close319.95
  • 52 Week High369.00
  • 52 Week High Date04/04/22
  • 52 Week Low123.00
  • 52 Week Low Date11/29/21
  • Market Cap103.02M
  • Shares Out26.2M
  • 10 Day Average Volume41,816.77
  • Dividend4.50
  • Dividend Yield1.41%
  • Beta-
  • YTD % Change78.39

RATIOS/PROFITABILITY

  • EPS (TTM)7.47
  • P/E (TTM)42.84
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date10/29/2021
  • Div Amount4.00
  • Split Date-
  • Split Factor-

Latest On Jagsonpal Pharmaceuticals Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients. The Company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. The Company’s products include categories include Pharma, Naari and Shovacare. Pharma products include Actv24 M, Parvon Spas, Parvon 1000SR, Parvon Forte, Uterone SR 300, Uterone 200mg...
Rajpal Kochhar
Executive Chairman of the Board, Managing Director
S. V. Subha Rao
Chief Financial Officer
Address
T 210J, Shahpurjat
New Delhi
110049
India